Ken Ikegami, Ryo Sasaki, Ryuta Morihara, Masahiro Ishida, Akinori Kinoshita, Chika Matsuoka et al. Response to “Specific MOG Antibody Testing With Quantitative Assessment of Antibody Positivity Is Indispensable for MOGAD Diagnosis”. // Neurology and Clinical Neuroscience. – 2026. – DOI: 10.1002/ncn3.70168. – URL: https://onlinelibrary.wiley.com/doi/10.1002/ncn3.70168?af=R
Ken Ikegami, Ryo Sasaki, Ryuta Morihara, Masahiro Ishida, Akinori Kinoshita, Chika Matsuoka, Tomohito Kawano, Yuki Taira, Yosuke Osakada, Mami Takemoto, Taijun Yunoki, Toru Yamashita, & Hiroyuki Ishiura (2026). Response to “Specific MOG Antibody Testing With Quantitative Assessment of Antibody Positivity Is Indispensable for MOGAD Diagnosis”. Neurology and Clinical Neuroscience. https://doi.org/10.1002/ncn3.70168
Ken Ikegami, et al. “Response to “Specific MOG Antibody Testing With Quantitative Assessment of Antibody Positivity Is Indispensable for MOGAD Diagnosis”.” Neurology and Clinical Neuroscience, 2026. doi:10.1002/ncn3.70168.
@article{Ikegami2026,
title = {Response to “Specific MOG Antibody Testing With Quantitative Assessment of Antibody Positivity Is Indispensable for MOGAD Diagnosis”},
author = {Ikegami, Ken and Sasaki, Ryo and Morihara, Ryuta and Ishida, Masahiro and Kinoshita, Akinori and Matsuoka, Chika and Kawano, Tomohito and Taira, Yuki and Osakada, Yosuke and Takemoto, Mami and Yunoki, Taijun and Yamashita, Toru and Ishiura, Hiroyuki},
journal = {Neurology and Clinical Neuroscience},
year = {2026},
doi = {10.1002/ncn3.70168},
url = {https://onlinelibrary.wiley.com/doi/10.1002/ncn3.70168?af=R}
}